

Losartan Market Valued at USD 1.5 Billion in 2023, Projected to Reach USD 2.3 Billion by 2034 | TMR Research
Losartan, an angiotensin II receptor blocker (ARB), is widely used to treat hypertension and certain cardiovascular conditions. With the increasing prevalence of hypertension and kidney